Literature DB >> 28509306

AP-VAS 2012 case report: a case of ANCA-negative crescentic glomerulonephritis complicating multiple opportunistic infections in the digestive tract.

Shinya Yamamoto1, Tetsuya Makiishi2, Yuko Sogabe3, Tomoyuki Shirase4, Sayako Maeda2.   

Abstract

Crescentic glomerulonephritis (GN) is one of the common causes of rapidly progressive glomerulonephritis (RPGN). Pauci-immune crescentic GN is usually associated with anti-neutrophil cytoplasmic antibody (ANCA). However, patients with pauci-immune crescentic GN who lack ANCAs have recently been reported. Approximately 10-30 % of patients with pauci-immune crescentic GN lack ANCAs. The clinical characteristics of patients with ANCA-negative pauci-immune crescentic GN are not entirely the same as patients with ANCA-positive GN, and this suggests that ANCA-negative and ANCA-positive pauci-immune crescentic GN might be different disease entities. We report a patient with ANCA-negative crescentic GN complicated with multiple opportunistic infections (Candida albicans, herpes simplex virus, and Cytomegalovirus) in the digestive tract during the course of immunosuppressive therapy. After antifungal and antiviral therapies including itraconazole, valaciclovir, and ganciclovir, she recovered from multiple opportunistic infections. The occurrence of comorbid opportunistic infections during the course of immunosuppressive therapy may not be rare in the elderly. However, a case of multiple opportunistic infections limited to the digestive tract is very rare.

Entities:  

Keywords:  ANCA-negative; Candida albicans; Colitis; Crescentic glomerulonephritis; Cytomegalovirus; Esophagitis; Herpes simplex virus; Opportunistic infection

Year:  2013        PMID: 28509306      PMCID: PMC5411559          DOI: 10.1007/s13730-013-0091-0

Source DB:  PubMed          Journal:  CEN Case Rep        ISSN: 2192-4449


  13 in total

Review 1.  Anti-neutrophil cytoplasm-associated glomerulonephritis.

Authors:  Matthew David Morgan; Lorraine Harper; Julie Williams; Caroline Savage
Journal:  J Am Soc Nephrol       Date:  2006-04-19       Impact factor: 10.121

Review 2.  ANCA-negative pauci-immune crescentic glomerulonephritis.

Authors:  Min Chen; Cees G M Kallenberg; Ming-Hui Zhao
Journal:  Nat Rev Nephrol       Date:  2009-04-28       Impact factor: 28.314

Review 3.  Use of glucocorticoids and risk of infections.

Authors:  Maurizio Cutolo; Bruno Seriolo; Carmen Pizzorni; Maria Elena Secchi; Stefano Soldano; Sabrina Paolino; Paola Montagna; Alberto Sulli
Journal:  Autoimmun Rev       Date:  2008-08-12       Impact factor: 9.754

4.  Antineutrophil cytoplasmic autoantibody-negative Pauci-immune crescentic glomerulonephritis.

Authors:  Min Chen; Feng Yu; Su-Xia Wang; Wan-Zhong Zou; Ming-Hui Zhao; Hai-Yan Wang
Journal:  J Am Soc Nephrol       Date:  2007-01-10       Impact factor: 10.121

5.  Risk of infectious complications in patients taking glucocorticosteroids.

Authors:  A E Stuck; C E Minder; F J Frey
Journal:  Rev Infect Dis       Date:  1989 Nov-Dec

6.  ANCA-associated glomerulonephritis in the very elderly.

Authors:  Andrew S Bomback; Gerald B Appel; Jai Radhakrishnan; Shayan Shirazian; Leal C Herlitz; Barry Stokes; Vivette D D'Agati; Glen S Markowitz
Journal:  Kidney Int       Date:  2010-12-15       Impact factor: 10.612

7.  Multiple opportunistic infections after high-dose steroid therapy for giant cell arteritis in a patient previously treated with a purine analog.

Authors:  Parham Sendi; Angela Wolf; Peter Graber; Werner Zimmerli
Journal:  Scand J Infect Dis       Date:  2006

8.  ANCA-negative pauci-immune renal vasculitis: histology and outcome.

Authors:  Ute Eisenberger; Fadi Fakhouri; Philippe Vanhille; Hélène Beaufils; Alfred Mahr; Loic Guillevin; Philippe Lesavre; Laure-Hélène Noël
Journal:  Nephrol Dial Transplant       Date:  2005-04-26       Impact factor: 5.992

9.  Clinicoepidemiological manifestations of RPGN and ANCA-associated vasculitides: an 11-year retrospective hospital-based study in Japan.

Authors:  Yusuke Suzuki; Yukihiko Takeda; Daisuke Sato; Yasuhiko Kanaguchi; Yuichi Tanaka; Shigeto Kobayashi; Kazuo Suzuki; Hiroshi Hashimoto; Shoichi Ozaki; Satoshi Horikoshi; Yasuhiko Tomino
Journal:  Mod Rheumatol       Date:  2009-10-10       Impact factor: 3.023

10.  Immediate and delayed impact of oral glucocorticoid therapy on risk of serious infection in older patients with rheumatoid arthritis: a nested case-control analysis.

Authors:  William G Dixon; Michal Abrahamowicz; Marie-Eve Beauchamp; David W Ray; Sasha Bernatsky; Samy Suissa; Marie-Pierre Sylvestre
Journal:  Ann Rheum Dis       Date:  2012-01-12       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.